HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02696 HENLIUS

Market Closed 07-03 16:08:15

66.700

-2.000

-2.91%

High70.650	Low66.500	Vol648.18K
Open69.600	D1 Closing68.700	Amplitude6.04%
Mkt Cap36.35B	Tradable Cap23.21B	Total Shares545.00M
T/O43.97M	T/O Rate0.19%	Tradable Shares348.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":66.7,"timestamp":1783066095007,"preClose":68.7,"halted":0,"volume":648182,"delay":0,"changeRate":-0.02911208151382824,"floatShares":348000000,"shares":545000000,"eps":1.7453422305550106,"marketStatus":"Market Closed","change":-2,"latestTime":"07-03 16:08:15","open":69.6,"high":70.65,"low":66.5,"amount":43971107,"amplitude":0.060408,"askPrice":66.7,"askSize":2500,"bidPrice":66.6,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":1.7457838791919984,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":7,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":68.7,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.40750627024067915,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02696","defaultTab":"news","newsList":[{"id":"2648502163","title":"Is Shanghai Henlius Biotech (SEHK:2696) Pricey Or Undervalued After Its Canada Denosumab Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502163","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648502163?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:47","pubTimestamp":1782992822,"startTime":"0","endTime":"0","summary":"Canadian denosumab launch puts Shanghai Henlius Biotech in focus\nShanghai Henlius Biotech (SEHK:2696) is drawing attention after announcing that its denosumab biosimilars BILDYOS and TUZEMTY are now available in Canada through partner Organon, covering all indications of the reference products.\nThe launch extends Henlius’s reach beyond its primarily China based revenue by bringing its osteoporosis and oncology supportive care portfolio into a mature biologics market, where Organon holds...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/is-shanghai-henlius-biotech-sehk2696-pricey-or-undervalued-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/is-shanghai-henlius-biotech-sehk2696-pricey-or-undervalued-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02696","BK4588","HK0000165453.HKD","XBI","HK0000320264.USD","BK4581","HK0000306685.HKD","HK0000306701.USD","DCF","BK4585","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119969085","title":"Henlius Shares Surge in Early Trading Following NHS Inclusion Recommendation for Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1119969085","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119969085?lang=en_us&edition=fundamental","pubTime":"2026-07-02 11:18","pubTimestamp":1782962305,"startTime":"0","endTime":"0","summary":"HENLIUS (SEHK: 02696) shares experienced a significant rise of nearly 12% during the morning trading session.At the time of reporting, the stock was up 7.07%, trading at HK$68.95 with a turnover of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NICE","HK0000306701.USD","BK4023","BK4585","BK1161","VXUS","02696","BK4566","BK4543","BK4588","HK0000320223.HKD","HK0000165453.HKD","HK0000320264.USD","IE00BFMHRM44.USD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168355373","title":"HENLIUS doses first patient in Phase 1 trial of bispecific ADC HLX48 for advanced solid tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1168355373","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168355373?lang=en_us&edition=fundamental","pubTime":"2026-06-30 17:23","pubTimestamp":1782811396,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech, Inc. (HENLIUS) has initiated patient dosing in a first-in-human Phase 1 clinical study of HLX48, an antibody–drug conjugate (ADC) that simultaneously targets EGFR and c-MET,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647539433","title":"Shanghai Henlius Doses First Patient in Phase 1 HLX48 Trial for Advanced Solid Tumors in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2647539433","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647539433?lang=en_us&edition=fundamental","pubTime":"2026-06-30 17:14","pubTimestamp":1782810881,"startTime":"0","endTime":"0","summary":"Shanghai Henlius doses first patient in Phase 1 HLX48 trial for advanced solid tumors in ChinaShanghai Henlius Biotech dosed the first patient in a first-in-human Phase 1 study of HLX48, a bispecific ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL6rZ3PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696","HK0000306685.HKD","HK0000306701.USD","00656","HK0000320223.HKD","BK1230","HK0000165453.HKD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143959790","title":"HENLIUS Shares Surge Over 13% on EU Approval for New Lung Cancer Indication of H Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1143959790","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143959790?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:44","pubTimestamp":1782701061,"startTime":"0","endTime":"0","summary":"Shares of HENLIUS (02696) surged more than 13% during the morning trading session. At the time of writing, the stock was up 13.33% to HK$62.9, with a turnover of HK$34.75 million.The significant...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK4585","BK1161","VXUS","HK0000320223.HKD","HK0000306685.HKD","FSXEmain","02696","BK4588","HK0000320264.USD","HK0000306701.USD","FESXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185343966","title":"HENLIUS Maintains Top-Tier Status with Sixth Consecutive Inclusion in China's Top 100 Pharmaceutical Innovators List","url":"https://stock-news.laohu8.com/highlight/detail?id=1185343966","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185343966?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:12","pubTimestamp":1782483163,"startTime":"0","endTime":"0","summary":"In a recent announcement, the \"2026 China Top 100 Pharmaceutical Innovators\" list has been released. HENLIUS (02696.HK) has secured its position on this prestigious list for the sixth consecutive...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","HK0000165453.HKD","HK0000306701.USD","BK0250","BK1161","BK0188","BK0028","BK0082","02696","600056","HK0000306685.HKD","BK0010","HK0000320264.USD","HK0000320223.HKD","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107543120","title":"New Energy System Blueprint and Rural EV Initiative Unveiled as Key Stocks Report Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1107543120","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107543120?lang=en_us&edition=fundamental","pubTime":"2026-06-26 07:26","pubTimestamp":1782429979,"startTime":"0","endTime":"0","summary":"Two major national plans have been announced, focusing on the development of a new energy system by 2030 and a new round of rural new energy vehicle promotion. Key Developments The National...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1613","BK1227","BK1502","BK1113","BK1615","BK1589","BK1512","HK0000320264.USD","BK4588","HK0000252160.HKD","02616","80020","HK0000165453.HKD","BK1109","HK0000252152.HKD","03998","BK1574","BK1161","HK0000306685.HKD","HK0000320223.HKD","LU1675838814.USD","HK0000306701.USD","159945","HK0000500386.USD","BK4585","02696","BK1500","09879","09887","LU1808992512.USD","00020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646583877","title":"Henlius Biotech Gets EU Clearance for New Indication of Serplulimab Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2646583877","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646583877?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:35","pubTimestamp":1782387309,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech  obtained approval for a new indication of its serplulimab injection from the European Commission, according to a Thursday Hong Kong bourse filing.The approved indication is for serplulimab in combination with carboplatin and nab-paclitaxel for the first-line treatment of adults with unresectable, locally advanced or metastatic squamous non-small cell lung carcinoma.The new indication has been approved in all EU member states as well as in Iceland, Liechtenstein, and Norway.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4585","HK0000306685.HKD","BK4156","XBI","HK0000165453.HKD","BK1161","BK4588","02696","HK0000320223.HKD","HK0000320264.USD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124175635","title":"HENLIUS Announces First US Patient Dosed in Global Phase 1 Trial for HLX13, an Ipilimumab Biosimilar, in First-Line Unresectable Advanced Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1124175635","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124175635?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:28","pubTimestamp":1782383317,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced a significant milestone in its clinical development program. The company has dosed the first patient in the United States for its international multi-center Phase 1...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HK0000306701.USD","HCC","HK0000320223.HKD","BK1161","HK0000306685.HKD","HK0000320264.USD","02696","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187817277","title":"HENLIUS secures European Commission approval for Serplulimab’s first-line sqNSCLC indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1187817277","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187817277?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:26","pubTimestamp":1782383197,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (HENLIUS) has received European Commission (EC) authorisation for a new indication of its anti-PD-1 monoclonal antibody serplulimab (EU trade name: HETRONIFLY). The therapy,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191553204","title":"HENLIUS Doses First U.S. Patient in Global Phase 1 Trial of Ipilimumab Biosimilar HLX13 for Unresectable Advanced HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=1191553204","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191553204?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:25","pubTimestamp":1782383152,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech, Inc. (HENLIUS) has administered the first U.S. dose in its international, multicenter Phase 1 clinical study of HLX13, a biosimilar to Bristol Myers Squibb’s Ipilimumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646871962","title":"Shanghai Henlius Says First US Patient Dosed in Phase 1 Trial of Ipilimumab Biosimilar HLX13 for Advanced Liver Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2646871962","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646871962?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:21","pubTimestamp":1782382911,"startTime":"0","endTime":"0","summary":"Shanghai Henlius says first US patient dosed in Phase 1 trial of ipilimumab biosimilar HLX13 for advanced liver cancerShanghai Henlius Biotech reported first US patient dosed in an international Phase","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL18wmPc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","BK1230","HK0000165453.HKD","02696","00656","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109806956","title":"HENLIUS Receives EU Approval for Serplulimab's Expanded Use in Advanced Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1109806956","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109806956?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:10","pubTimestamp":1782382239,"startTime":"0","endTime":"0","summary":"The European Commission has granted approval for an expanded indication of HENLIUS (HKEX: 02696)'s self-developed Serplulimab injection. This new approval covers the use of Serplulimab in combination...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","HK0000165453.HKD","HK0000306685.HKD","HK0000320264.USD","02696","HK0000320223.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879256","title":"EU Commission Approves Henlius Serplulimab Combo for First-line Squamous NSCLC Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879256","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879256?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:03","pubTimestamp":1782381791,"startTime":"0","endTime":"0","summary":"EU Commission approves Henlius serplulimab combo for first-line squamous NSCLC indicationEuropean Commission cleared serplulimab (Hetronifly) with carboplatin, nab-paclitaxel for first-line adult unre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL4b6F22:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00656","HK0000320264.USD","HK0000306685.HKD","BK1161","HK0000165453.HKD","BK1230","HK0000306701.USD","HK0000320223.HKD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879419","title":"Shanghai Henlius Biotech - European Commission Approves New Indication for Serplulimab (hetronifly) in Sqnsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879419?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:02","pubTimestamp":1782381778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42X01W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","HK0000320223.HKD","02696","HK0000306701.USD","HK0000306685.HKD","HK0000320264.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108962855","title":"HENLIUS Shares Rise on Canadian Commercial Launch of Denosumab Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1108962855","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108962855?lang=en_us&edition=fundamental","pubTime":"2026-06-24 10:28","pubTimestamp":1782268101,"startTime":"0","endTime":"0","summary":"Shares of HENLIUS (02696) climbed nearly 4% in Hong Kong trading. At the time of writing, the stock was up 3.98% to HK$65.05, with a turnover of approximately HK$10.51 million. The catalyst for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","IPOS","HK0000320264.USD","BK4588","BK1161","VXUS","HK0000320223.HKD","HK0000165453.HKD","BK4585","HK0000306685.HKD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645788239","title":"Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of Bildyos® (Denosumab Injection) and Tuzemty® (Denosumab Injection), Biosimilars to Prolia and Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2645788239","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645788239?lang=en_us&edition=fundamental","pubTime":"2026-06-23 17:31","pubTimestamp":1782207076,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nFWN42V0BW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","HK0000306685.HKD","HK0000320264.USD","HK0000165453.HKD","HK0000306701.USD","02696","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645099773","title":"Shanghai Henlius Biotech (SEHK:2696) Stock Could Be Worth A Look After China Oncology Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2645099773","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645099773?lang=en_us&edition=fundamental","pubTime":"2026-06-21 03:31","pubTimestamp":1781983901,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) has just cleared two regulatory hurdles that matter for investors, with GMP approval for HANBEIYOU production in China and a new gastric cancer indication for its HANSIZHUANG immunotherapy.\nSee our latest analysis for Shanghai Henlius Biotech.\nThese regulatory approvals arrive after a mixed stretch for Shanghai Henlius Biotech’s stock, with the share price up 7.51% year to date but down 11.45% over the past month. The 1-year total shareholder return of...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-stock-could-be-worth-a-loo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-stock-could-be-worth-a-loo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000165453.HKD","DCF","02696","XBI","HK0000320264.USD","BK1161","BK4588","HK0000320223.HKD","HK0000306701.USD","BK4581","HK0000306685.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644771187","title":"Fosun Pharma Unit Passes GMP Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2644771187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644771187?lang=en_us&edition=fundamental","pubTime":"2026-06-18 12:19","pubTimestamp":1781756374,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  subsidiary, Shanghai Henlius Biotech , passed a drug GMP or good manufacturing practice inspection, according to a Shanghai bourse filing on Thursday.The Shanghai Municipal Medical Products Administration made the inspection at Henlius' manufacturing facility in Songjiang District, which produces the breast cancer drug Hanbeiyou or pertuzumab injection.The company was found to be compliant with GMP requirements.The pharmaceutical company's Shanghai shares rose 2% during the morning trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0012","BK0187","BK0028","BK1593","02196","BK0183","BK0096","BK1515","02696","BK0060","HK0000306685.HKD","BK0175","BK1161","BK1191","600196","HK0000165453.HKD","HK0000320264.USD","BK0188","HK0000306701.USD","BK0196","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644779042","title":"Fosun Pharma Gets China Nod to Trial HLX3902 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2644779042","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644779042?lang=en_us&edition=fundamental","pubTime":"2026-06-18 11:52","pubTimestamp":1781754725,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical , through its subsidiary Shanghai Henlius Biotech , received approval from China's National Medical Products Administration for the clinical trials of HLX3902 injection, according to a Shanghai bourse filing on Thursday.The drug will be tested as a treatment for metastatic castration-resistant prostate cancer and other advanced solid tumors.The pharmaceutical company's Shanghai shares rose 2% during the morning trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0183","BK0239","02696","BK0060","BK1191","600196","BK0196","HK0000306701.USD","HK0000320264.USD","BK0187","HK0000320223.HKD","BK0175","BK0188","02196","HK0000306685.HKD","BK1515","BK0012","BK0028","BK0096","BK1593","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.2018},{"period":"1month","weight":0.1402},{"period":"3month","weight":-0.1292},{"period":"6month","weight":0.1382},{"period":"1year","weight":0.1921},{"period":"ytd","weight":0.1691}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Henlius Biotech Inc is a China-based company principally engaged in biopharmaceutical research and development, biopharmaceutical services and biopharmaceutical production and sales. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044394},{"month":2,"riseRate":0.714286,"avgChangeRate":0.117695},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.008815},{"month":4,"riseRate":0.857143,"avgChangeRate":0.12138},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033714},{"month":6,"riseRate":0.571429,"avgChangeRate":0.085211},{"month":7,"riseRate":0.571429,"avgChangeRate":0.064639},{"month":8,"riseRate":0.5,"avgChangeRate":-0.024213},{"month":9,"riseRate":0,"avgChangeRate":-0.127435},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.025526},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058675},{"month":12,"riseRate":0.714286,"avgChangeRate":-0.023816}],"exchange":"SEHK","name":"HENLIUS","nameEN":"HENLIUS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HENLIUS,02696,HENLIUS股票,HENLIUS股票老虎,HENLIUS股票老虎国际,HENLIUS行情,HENLIUS股票行情,HENLIUS股价,HENLIUS股市,HENLIUS股票价格,HENLIUS股票交易,HENLIUS股票购买,HENLIUS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}